Delivery Order SPE2DR25D2212-SPE2DR26FB9FT
Award Date 11/10/25
Potential Completion Date 11/12/25
Potential Value $14K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $34,983.20 on September 4, 2025, for Zepbound (semaglutide) 5 mg/0.5 mL pens with a completion date of September 5, 2025. This is a firm fixed-price, non-competitive delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 9, 2025, for the supply of Zepbound (semaglutide) 10 mg/0.5 mL pen injectors with a ceiling value of $15,095.99. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through an open procurement process. The order is scheduled for completion by November 10, 2025, with performance occurring at AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,785.59 to AmerisourceBergen Drug Corp for the supply of Zepbound (semaglutide) 12.5 mg/0.5 mL pens on July 18, 2025, with completion scheduled for July 21, 2025. This competitively awarded, firm fixed-price delivery order represents part of AmerisourceBergen's broader pharmaceutical supply operations supporting federal medical procurement needs. The company, headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,060.06 to AmerisourceBergen Drug Corp for the supply of Zepbound (semaglutide) 12.5 mg/0.5 ml pen injections. This firm fixed-price delivery order, awarded on October 31, 2025, with completion targeted for November 3, 2025, represents a purchase of pharmaceutical products to support federal medical supply needs. The award was made on a competitive basis with no set-aside designation. AmerisourceBergen, headquartered in...
- The Defense Logistics Agency awarded a $19,343.26 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Zepbound (semaglutide) 10 mg/0.5 mL pens. This competitively awarded, firm fixed-price contract is classified as a non-set-aside procurement and requires completion by July 25, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,142.48 to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Zepbound (semaglutide) 2.5 mg/0.5 mL pens. This is a competitively awarded, firm fixed-price delivery order with no set-aside designation and an ultimate completion date of August 11, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award falls under the company's substantial Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a $15,640.67 firm fixed price delivery order to AmerisourceBergen Drug Corp for Zepbound (semaglutide) 5 mg/0.5 mL pens on September 23, 2025, with completion expected by September 24, 2025. This award was made without a set-aside designation, indicating open competition. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary headquarters and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $38,077.55 to AmerisourceBergen Drug Corp for the supply of Zepbound (semaglutide) 7.5 mg/0.5 mL pens on August 6, 2025, with an ultimate completion date of August 7, 2025. This is a firm fixed-price delivery order issued under a non-competitive set-aside arrangement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a $2,761.36 delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Zepbound (semaglutide) 2.5 mg/0.5 mL pens in 0.5 mL unit doses. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of October 30, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $38,195.64 delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Zepbound (semaglutide) 2.5 mg/0.5 mL pens in 0.5 mL quantities. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award, and is scheduled for completion by September 18, 2025. The contract will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...